BACKGROUND: In Africa before the introduction of measles vaccination, measles primarily affected young children. To describe measles epidemiology in Africa since the start of accelerated measles control activities in 2001, we analyzed regional measles case-based surveillance data for 2002-2009. METHODS: Country-years were grouped by 10-year moving average of routine measles vaccination coverage (aMCV1). Age was log transformed, and pair-wise comparisons of means were made. A χ(2) test was used to assess association between coverage and age groups. Cumulative percent curves and percentiles of age, dot plots with Loess curve, and Spearman rank correlation coefficient were calculated. RESULTS: Of 180,284 suspected cases, 73,009 (41%) were confirmed as measles. Of these, the mean age was 79 months (median, 36 months; interquartile range, 16-96 months) and significantly younger in country-years with <50% aMCV1 than those with 50%-74% aMCV1 (P=.03) and ≥75% (P=.02). With increasing coverage, there was a slight decrease in age in the 10th and 25th and moderate increase in age in the 50th, 75th, and 90th percentiles. CONCLUSIONS: During 2002-2009, the median age of confirmed measles was 36 months. In countries with ≥50% aMCV1 coverage compared with low-coverage countries, age shifted to older children and young adults; for infants, age decreased slightly with higher coverage.
BACKGROUND: In Africa before the introduction of measles vaccination, measles primarily affected young children. To describe measles epidemiology in Africa since the start of accelerated measles control activities in 2001, we analyzed regional measles case-based surveillance data for 2002-2009. METHODS: Country-years were grouped by 10-year moving average of routine measles vaccination coverage (aMCV1). Age was log transformed, and pair-wise comparisons of means were made. A χ(2) test was used to assess association between coverage and age groups. Cumulative percent curves and percentiles of age, dot plots with Loess curve, and Spearman rank correlation coefficient were calculated. RESULTS: Of 180,284 suspected cases, 73,009 (41%) were confirmed as measles. Of these, the mean age was 79 months (median, 36 months; interquartile range, 16-96 months) and significantly younger in country-years with <50% aMCV1 than those with 50%-74% aMCV1 (P=.03) and ≥75% (P=.02). With increasing coverage, there was a slight decrease in age in the 10th and 25th and moderate increase in age in the 50th, 75th, and 90th percentiles. CONCLUSIONS: During 2002-2009, the median age of confirmed measles was 36 months. In countries with ≥50% aMCV1 coverage compared with low-coverage countries, age shifted to older children and young adults; for infants, age decreased slightly with higher coverage.
Authors: Catherine G Sutcliffe; Kelly Searle; Hellen K Matakala; Michelle P Greenman; Kaitlin Rainwater-Lovett; Philip E Thuma; William J Moss Journal: Pediatr Infect Dis J Date: 2017-03 Impact factor: 2.129
Authors: Christopher J Fonnesbeck; Katriona Shea; Spencer Carran; Jose Cassio de Moraes; Christopher Gregory; James L Goodson; Matthew J Ferrari Journal: J R Soc Interface Date: 2018-03 Impact factor: 4.118
Authors: Bruce Y Lee; Patrick T Wedlock; Leila A Haidari; Kate Elder; Julien Potet; Rachel Manring; Diana L Connor; Marie L Spiker; Kimberly Bonner; Arjun Rangarajan; Delphine Hunyh; Shawn T Brown Journal: Vaccine Date: 2017-04-25 Impact factor: 3.641
Authors: Alyssa S Parpia; Laura A Skrip; Elaine O Nsoesie; Moise C Ngwa; Aristide S Abah Abah; Alison P Galvani; Martial L Ndeffo-Mbah Journal: Ann Epidemiol Date: 2019-11-06 Impact factor: 3.797
Authors: Vincent Dossou Sodjinou; Alfred Douba; Marcellin Mengouo Nimpa; Yolande Vuo Masembe; Mireille Randria; Charlotte Faty Ndiaye Journal: Pan Afr Med J Date: 2020-09-05
Authors: Ikechukwu U Ogbuanu; Clementine Muroua; Martiena Allies; Kennedy Chitala; Sue Gerber; Primus Shilunga; Petrus Mhata; Jennifer L Kriss; Lucille Caparos; Sheilagh B Smit; Roselina J De Wee; James L Goodson Journal: S Afr Med J Date: 2016-06-17